BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33974272)

  • 1. Molecular pathology in the cancer clinic - where are we now and where are we headed?
    Guillen A; Smallwood K; Killick DR
    J Small Anim Pract; 2021 Jul; 62(7):507-520. PubMed ID: 33974272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief Review.
    Vranic S; Gatalica Z
    Acta Med Acad; 2021 Apr; 50(1):47-57. PubMed ID: 34075763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards the Delivery of Precision Veterinary Cancer Medicine.
    Katogiritis A; Khanna C
    Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):809-818. PubMed ID: 31256903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
    Miyachi H
    Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine.
    Masood S
    Breast J; 2020 Jan; 26(1):27-34. PubMed ID: 31876097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular pathology of cancer: from pan-genomics to post-genomics.
    Huntsman DG; Ladanyi M
    J Pathol; 2018 Apr; 244(5):509-511. PubMed ID: 29436707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.
    Ogino S; Nishihara R; VanderWeele TJ; Wang M; Nishi A; Lochhead P; Qian ZR; Zhang X; Wu K; Nan H; Yoshida K; Milner DA; Chan AT; Field AE; Camargo CA; Williams MA; Giovannucci EL
    Epidemiology; 2016 Jul; 27(4):602-11. PubMed ID: 26928707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histo-genomics: digital pathology at the forefront of precision medicine.
    Barsoum I; Tawedrous E; Faragalla H; Yousef GM
    Diagnosis (Berl); 2019 Aug; 6(3):203-212. PubMed ID: 30827078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of molecular pathology, epidemiology and social science for global precision medicine.
    Nishi A; Milner DA; Giovannucci EL; Nishihara R; Tan AS; Kawachi I; Ogino S
    Expert Rev Mol Diagn; 2016; 16(1):11-23. PubMed ID: 26636627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics-Enabled Precision Medicine for Cancer.
    Roos A; Byron SA
    Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology in therapeutics: where are we now, and where are we going?
    Harrison DJ; Faratian D
    Curr Drug Targets; 2012 Nov; 13(12):1473-4. PubMed ID: 22974390
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
    Donovan MJ; Cordon-Cardo C
    Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation matters in precision medicine: A future to believe in.
    Dey N; Williams C; Leyland-Jones B; De P
    Cancer Treat Rev; 2017 Apr; 55():136-149. PubMed ID: 28371665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
    Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
    Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative omics analyses broaden treatment targets in human cancer.
    Sengupta S; Sun SQ; Huang KL; Oh C; Bailey MH; Varghese R; Wyczalkowski MA; Ning J; Tripathi P; McMichael JF; Johnson KJ; Kandoth C; Welch J; Ma C; Wendl MC; Payne SH; Fenyö D; Townsend RR; Dipersio JF; Chen F; Ding L
    Genome Med; 2018 Jul; 10(1):60. PubMed ID: 30053901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
    Schütte M; Ogilvie LA; Rieke DT; Lange BMH; Yaspo ML; Lehrach H
    Public Health Genomics; 2017; 20(2):70-80. PubMed ID: 28595192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variant interpretation in molecular pathology and oncology : An introduction].
    Horak P; Leichsenring J; Kreutzfeldt S; Kazdal D; Teleanu V; Endris V; Volckmar AL; Renner M; Kirchner M; Heilig CE; Neumann O; Schirmacher P; Fröhling S; Stenzinger A
    Pathologe; 2021 Jul; 42(4):369-379. PubMed ID: 33938987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.